Whipple’s disease (WD) is a rare, chronic, systemic infectious bacterial disease caused by Tropheryma whipplei that affects gastrointestinal system, especially, the small intestine. The infection may spread to any part of the body but mostly it affects the central nervous system, joints, lungs, heart, and eyes. Ongoing research and clinical trial to find effective cure drive the growth of market. Advancement in medical technology and increasing awareness about this disease boost the market growth. Avail a Free Sample Copy at https://www.marketresearchfuture.com/sample_request/4094 The “global Whipple’s Disease Industry is expected to grow at the CAGR of ~3.1% during the forecast period and is estimated to reach USD 255.3 million by 2023.” Competitive Analysis: Some of the key players in this market are – AbbVie Inc. (US) Allergan (Republic of Ireland) Bayer AG (Germany) Bristol-Myers Squibb Company (US) Hoffmann-La Roche Ltd. (Switzerland) Henr...